Publications by authors named "Kevin Adamzek"

Claim this Profile
P
Preclinical targeting of liver fibrosis with a Zr-labeled Fibrobody® directed against platelet derived growth factor receptor-β.
Joey A Muns, Erik Schooten, Rychon D J van Dasselaar, Yvet E Noordman, Kevin Adamzek

Eur J Nucl Med Mol Imaging· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Learning, memory and blood-brain barrier pathology in Duchenne muscular dystrophy mice lacking Dp427, or Dp427 and Dp140.
Minou Verhaeg, Kevin Adamzek, Davy van de Vijver, Kayleigh Putker, Sarah Engelbeen

Genes Brain Behav· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Homogeneous tumor targeting with a single dose of HER2-targeted albumin-binding domain-fused nanobody-drug conjugates results in long-lasting tumor remission in mice.
Katerina T Xenaki, Bram Dorrestijn, Joey A Muns, Kevin Adamzek, Sofia Doulkeridou

Theranostics· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Premature termination codons in the gene cause reduced local mRNA synthesis.
Raquel García-Rodríguez, Monika Hiller, Laura Jiménez-Gracia, Zarah van der Pal, Judit Balog, Kevin Adamzek

Proc Natl Acad Sci U S A· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A modified diet does not ameliorate muscle pathology in a mouse model for Duchenne muscular dystrophy.
Ingrid E C Verhaart, Davy van de Vijver, Joke W Boertje-van der Meulen, Kayleigh Putker, Kevin Adamzek

PLoS One· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
First platinum(II)-based metal-organic linker technology (Lx®) for a plug-and-play development of antibody-drug conjugates (ADCs).
Eugen Merkul, Niels J Sijbrandi, Joey A Muns, Ibrahim Aydin, Kevin Adamzek

Expert Opin Drug Deliv· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fully Automated Zr Labeling and Purification of Antibodies.
Alex J Poot, Kevin W A Adamzek, Albert D Windhorst, Maria J W D Vosjan, Saskia Kropf

J Nucl Med· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of [11C]vemurafenib employing a carbon-11 carbonylative Stille coupling and preliminary evaluation in mice bearing melanoma tumor xenografts.
Paul Slobbe, Albert D Windhorst, Kevin Adamzek, Marije Bolijn, Robert C Schuit

Oncotarget· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of the octadentate bifunctional chelator DFO*-pPhe-NCS and the clinically used hexadentate bifunctional chelator DFO-pPhe-NCS for Zr-immuno-PET.
Danielle J Vugts, Chris Klaver, Claudia Sewing, Alex J Poot, Kevin Adamzek

Eur J Nucl Med Mol Imaging· February 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Novel Platinum(II)-Based Bifunctional ADC Linker Benchmarked Using 89Zr-Desferal and Auristatin F-Conjugated Trastuzumab.
Niels J Sijbrandi, Eugen Merkul, Joey A Muns, Dennis C J Waalboer, Kevin Adamzek

Cancer Res· January 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Molecular imaging of aurora kinase A (AURKA) expression: Synthesis and preclinical evaluation of radiolabeled alisertib (MLN8237).
Jeroen A C M Goos, Joost Verbeek, Albert A Geldof, Annemieke C Hiemstra, Mark A van de Wiel, Kevin A Adamzek

Nucl Med Biol· January 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis